MIF and cancer: Investigations have recognized MIF as a central participant in the cancer-associated immune response, having the capacity to support the development of HNSCC by its pleiotropic roles in mediating hypoxia response, angiogenesis, and epithelial-mesenchymal transition (EMT) [83].